The effect of esketamine in patients with treatment‐resistant depression with and without comorbid anxiety symptoms or disorder

BACKGROUND: Comorbid anxiety is generally associated with poorer response to antidepressant treatment. This post hoc analysis explored the efficacy of esketamine plus an antidepressant in patients with treatment‐resistant depression (TRD) with or without comorbid anxiety. METHODS: TRANSFORM‐2, a dou...

Descripción completa

Detalles Bibliográficos
Autores principales: Daly, Ella J., Turkoz, Ibrahim, Salvadore, Giacomo, Fedgchin, Maggie, Ionescu, Dawn F., Starr, H. Lynn, Borentain, Stephane, Trivedi, Madhukar H., Thase, Michael E., Singh, Jaskaran B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291524/
https://www.ncbi.nlm.nih.gov/pubmed/34293233
http://dx.doi.org/10.1002/da.23193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291524/
https://www.ncbi.nlm.nih.gov/pubmed/34293233
http://dx.doi.org/10.1002/da.23193

Ejemplares similares